These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 19394731

  • 1. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A, Duncan N, Singh SK, Brown W, Dalby E, Edwards C, Lynch K, Prout V, Cairns T, Griffith M, McLean A, Palmer A, Taube D.
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [Abstract] [Full Text] [Related]

  • 2. A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
    Solomon LR, Cheesbrough JS, Ebah L, Al-Sayed T, Heap M, Millband N, Waterhouse D, Mitra S, Curry A, Saxena R, Bhat R, Schulz M, Diggle P.
    Am J Kidney Dis; 2010 Jun; 55(6):1060-8. PubMed ID: 20207458
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B.
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [Abstract] [Full Text] [Related]

  • 4. Prevention of tunneled cuffed hemodialysis catheter-related dysfunction and bacteremia by a neutral-valve closed-system connector: a single-center randomized controlled trial.
    Bonkain F, Racapé J, Goncalvez I, Moerman M, Denis O, Gammar N, Gastaldello K, Nortier JL.
    Am J Kidney Dis; 2013 Mar; 61(3):459-65. PubMed ID: 23228946
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cathasept Line Lock and Microbial Colonization of Tunneled Hemodialysis Catheters: A Multicenter Randomized Controlled Trial.
    Kanaa M, Wright MJ, Akbani H, Laboi P, Bhandari S, Sandoe JA.
    Am J Kidney Dis; 2015 Dec; 66(6):1015-23. PubMed ID: 26141306
    [Abstract] [Full Text] [Related]

  • 7. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study.
    Saxena AK, Panhotra BR.
    J Nephrol; 2005 Dec; 18(6):755-63. PubMed ID: 16358235
    [Abstract] [Full Text] [Related]

  • 8. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients.
    Weijmer MC, van den Dorpel MA, Van de Ven PJ, ter Wee PM, van Geelen JA, Groeneveld JO, van Jaarsveld BC, Koopmans MG, le Poole CY, Schrander-Van der Meer AM, Siegert CE, Stas KJ, CITRATE Study Group.
    J Am Soc Nephrol; 2005 Sep; 16(9):2769-77. PubMed ID: 16033861
    [Abstract] [Full Text] [Related]

  • 9. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters.
    Yon CK, Low CL.
    Am J Health Syst Pharm; 2013 Jan 15; 70(2):131-6. PubMed ID: 23292266
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Temporary hemodialysis catheters as a long-term vascular access in chronic hemodialysis patients.
    Ponikvar R, Buturović-Ponikvar J.
    Ther Apher Dial; 2005 Jun 15; 9(3):250-3. PubMed ID: 15967000
    [Abstract] [Full Text] [Related]

  • 13. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study): study protocol for a randomized controlled trial.
    Bruyère R, Soudry-Faure A, Capellier G, Binquet C, Nadji A, Torner S, Blasco G, Yannaraki M, Barbar SD, Quenot JP.
    Trials; 2014 Nov 19; 15():449. PubMed ID: 25409678
    [Abstract] [Full Text] [Related]

  • 14. A prospective, randomized, double-blind crossover study on the use of 5% citrate lock versus 10% citrate lock in permanent hemodialysis catheters.
    Meeus G, Kuypers DR, Claes K, Evenepoel P, Maes B, Vanrenterghem Y.
    Blood Purif; 2005 Nov 19; 23(2):101-5. PubMed ID: 15640601
    [Abstract] [Full Text] [Related]

  • 15. Catheter-related bacteremia in hemodialysis: which preventive measures to take?
    Silva J, Teixeira e Costa, Baptista A, Ramos A, Ponce P.
    Nephron Clin Pract; 2008 Nov 19; 110(4):c251-7. PubMed ID: 18974657
    [Abstract] [Full Text] [Related]

  • 16. Locking tunneled hemodialysis catheters with hypertonic saline (26% NaCl) and heparin to prevent catheter-related bloodstream infections and thrombosis: a randomized, prospective trial.
    Oguzhan N, Pala C, Sipahioglu MH, Cilan H, Durmaz S, Percin D, Unal A, Tokgoz B, Utas C, Oymak O.
    Ren Fail; 2012 Nov 19; 34(2):181-8. PubMed ID: 22260745
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A vancomycin-heparin lock solution for prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomized trial.
    Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG.
    Pediatrics; 2005 Aug 19; 116(2):e198-205. PubMed ID: 15995005
    [Abstract] [Full Text] [Related]

  • 19. An ethanol/sodium citrate locking solution compared to heparin to prevent hemodialysis catheter-related infections: a randomized pilot study.
    Vercaigne LM, Allan DR, Armstrong SW, Zacharias JM, Miller LM.
    J Vasc Access; 2016 Aug 19; 17(1):55-62. PubMed ID: 26660041
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.